openPR Logo
Press release

Investigation announced for Investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX)

03-15-2022 03:52 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares over potential securities laws violations.

An investigation for investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares over potential securities laws violations.

An investigation was announced over potential securities laws violations by Lexicon Pharmaceuticals, Inc. in connection with certain financial statements.

Investors who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Lexicon Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

The Woodlands, TX based Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products.

On February 28, 2022, Lexicon Pharmaceuticals, Inc. announced the voluntary withdrawal of the Company's New Drug Application for its glucose regulation drug, sotagliflozin, in order to correct a technical issue with the submission that had been recently identified by the Company.

Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) declined from $3.29 per share on February 10, 2022 to as low as $1.95 per share on March 14, 2022.

Those who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) here

News-ID: 2578229 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Lexicon

Interview with Olivia Luper, Founder of Lexicon Advisor Marketing, Interviewed o …
Image: https://authoritypresswire.com/wp-content/uploads/2025/03/2021.8.5-OliviaLuper-12__1_-removebg-preview.png Olivia Luper discusses content marketing Listen to the interview on the Business Innovators Radio Network: Interview with Olivia Luper, Founder of Lexicon Advisor Marketing - Business Innovators Radio Network [https://businessinnovatorsradio.com/interview-with-olivia-luper-founder-of-lexicon-advisor-marketing/] Digital content marketing has undergone a significant transformation over the years, shifting from a primary focus on quantity to an emphasis on high-quality, targeted content that resonates with specific audiences. This evolution reflects the changing landscape of consumer behavior and the
Vocal Processor Market to Witness Stunning Growth | Major Giants Shure, Boss, Le …
The latest independent research document on "Vocal Processor Market Size, Status, Type, Application and Forecast 2024-2030" with 123+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, emerging technologies, drivers, sales, opportunities, market viewpoint and Outlook. The Study is segmented by key a region that is accelerating the marketization. Vocal Processor study is a perfect mix
Relocation Management Software Market Is Booming Worldwide | Lexicon Relocation, …
Advance Market Analytics added research publication document on Worldwide Relocation Management Software Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Relocation Management Software market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2022 which is estimated and forecasted till
Investigation announced for Investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Lexicon Pharmaceuticals, Inc. Investors who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) and have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Lexicon Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders. The
Relocation Software Market Next Big Thing | Major Giants INSZoom, Lexicon Reloca …
Latest released the research study on Global Relocation Software Market, offers a detailed overview of the factors influencing the global business scope. Relocation Software Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Relocation Software. The study covers emerging player’s data, including: competitive
“From the Elusive Muse’s Lexicon” by Garry B. Grove is published by Grosve …
ISBN #978-1839753022 “From the Elusive Muse’s Lexicon” by Garry B. Grove is published by Grosvenor House Publishing About the Book: From the Elusive Muse's Lexicon is a second volume of poetry to accompany the earlier, "A Storm in Pandora's Tea Box". It touches upon a diverse range of subjects, from a homage to London's beloved River Thames, a trilogy of Coventry poems anticipating the City's role as UK City of Culture